Skip to main content
. 2014 Jun 18;9:141. doi: 10.1186/1748-717X-9-141

Table 2.

Treatment

  n %
Surgery N = 42
 
 
Hysterectomy and bilateral salpingo-oophorectomy
42
100%
Lymphadenectomy
 
 
 Pelvic
15
35.7%
 Pelvic and paraaortic
17
40.5%
 None
10
23.8%
Adjuvant chomotherapy N = 42
 
 
Carboplatin/paclitaxel
7
16.7%
None
35
83.3%
Adjuvant radiotherapy N = 42
 
 
Intravaginal HDR brachytherapy alone
5
11.9%
Intravaginal HDR brachytherapy and external beam radiotherapy 37 88.1%